Overall rank by patents
#11,016
Across all tracked assignees
USPTO PatentsView assignee record - 28 granted patents across 14 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F42B (EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION).
The verdict
Nexter holds 28 US patents across 14 technology areas, rank #11,016 of 50,000 tracked assignees.
Nexter Munitions has been granted 28 US utility patents between 2015 and 2025, placing Nexter Munitions at rank #11,016 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.3 claims per patent with primary concentration in F42B (EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION). As a Foreign Corporation, Nexter Munitions is one of the more focused assignees in the PatentsView dataset. By volume, Nexter sits between Nanjing Forestry University (28 patents, rank #11,012) and Nutramax Laboratories, Inc. (28 patents, rank #11,020) - the closest US assignees by grant volume. The composite Innovation Score of 38.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 11 in the 2015–2019 window, a +55% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nexter Munitions's 8.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nexter Munitions against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NANJING FORESTRY UNIVERSITY
28 patents
NATIONAL CHRISTMAS PRODUCTS LLC
28 patents
NEOGEN CORPORATION
28 patents
NEW WORLD MEDICAL, INC.
28 patents
NIPPON FILCON CO., LTD.
28 patents
NISSIN CHEMICAL INDUSTRY CO., LTD.
28 patents
NSE Products, Inc.
28 patents
NUTRAMAX LABORATORIES, INC.
28 patents
NEXTER MUNITIONS
28 patents
What this shows Nexter holds 28 patents at rank #11,016, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,016 in granted patent volume.
Other assignees with the most granted patents in Nexter's primary technology class.
Nexter's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 42% higher than 58% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 7.1% |
| 2016 | 3 | 10.7% |
| 2017 | 1 | 3.6% |
| 2018 | 1 | 3.6% |
| 2019 | 4 | 14.3% |
| 2020 | 2 | 7.1% |
| 2021 | 3 | 10.7% |
| 2022 | 6 | 21.4% |
| 2023 | 4 | 14.3% |
| 2024 | 1 | 3.6% |
| 2025 | 1 | 3.6% |
Top 14 of 14 technology areas
Overall rank by patents
#11,016
Across all tracked assignees
38.0 out of 100
How to use this portfolio
Nexter's 28 grants land it in the top 42% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.